LOADING
Comparing Merck & Company (MRK) and Snap Inc (SNAP) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | SNAP |
|---|---|---|
| Price | $123.54 | $4.68 |
| Change Today | -1.22% | -0.43% |
| Market Cap | $305.1B | $7.8B |
| P/E Ratio | 34.8 | -- |
| Forward P/E | 24.9 | 9.2 |
| PEG Ratio | 6.22 | 496.06 |
| EPS | $3.55 | $-0.24 |
| Revenue Growth (YoY) | 4.9% | 12.1% |
| Profit Margin | 13.6% | -6.7% |
| Return on Equity | 18.9% | -18.6% |
| Dividend Yield | 2.62% | -- |
| Beta | 0.20 | 1.05 |
| 52-Week High | $130.29 | $10.41 |
| 52-Week Low | $74.18 | $3.81 |
| Volume | 8.4M | 28.3M |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.